サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1269405

モバイル心臓テレメトリーデバイス市場（疾患別適応症：狭心症、アテローム性動脈硬化症、心不全、その他）-世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年

Mobile Cardiac Telemetry Device Market (Disease Indication: Angina Pectoris, Atherosclerosis, Heart Failure, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 183 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
モバイル心臓テレメトリーデバイス市場（疾患別適応症：狭心症、アテローム性動脈硬化症、心不全、その他）-世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年
出版日: 2023年03月28日
発行: Transparency Market Research
ページ情報: 英文 183 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

モバイル心臓テレメトリーデバイス市場- 調査範囲：

TMRの調査レポート「世界のモバイル心臓テレメトリーデバイス市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。本レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの期間における世界のモバイル心臓テレメトリーデバイス市場の収益を提供します。また、2023年から2031年までの世界のモバイル心臓テレメトリーデバイス市場のCAGRを掲載しています。

本レポートは、広範な調査を経て作成されました。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査作業の大部分を行っています。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、モバイル心臓テレメトリーデバイス市場を把握しました。

本レポートでは、世界のモバイル心臓テレメトリーデバイス市場の競合情勢を掘り下げています。世界のモバイル心臓テレメトリーデバイス市場で活動する主要企業が特定され、それぞれの企業が様々な属性でプロファイリングされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のモバイル心臓テレメトリーデバイス市場のプレイヤーの属性です。

目次

第1章 序文

  • 市場の定義と範囲
  • 市場セグメンテーション
  • 主な調査目的
  • 調査ハイライト

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場の概要

  • イントロダクション
    • 疾患適応の定義
    • 業界の進化/発展
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界市場の分析と予測、2017年～2031年

第5章 主な洞察

  • 技術的進歩
  • 法規制の分析
  • 疾病の発生率と有病率
  • COVID-19の影響分析

第6章 世界市場分析・予測：アプリケーション別

  • イントロダクションと定義
  • 主な発見と発展
  • 市場価値予測：アプリケーション別、2017年～2031年
    • リードベース
    • パッチベース
  • 市場魅力分析：アプリケーション別

第7章 世界市場分析・予測：疾患別適応症別

  • イントロダクションと定義
  • 主な調査結果/発展状況
  • 市場価値予測：疾患適応症別、2017-2031年
    • 狭心症
    • アテローム性動脈硬化症
    • 心不全
    • その他
  • 市場魅力：疾患適応症別

第8章 世界市場分析・予測：エンドユーザー別

  • イントロダクション＆定義
  • 主な調査結果・発展状況
  • 市場規模予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門クリニック
    • 診断センター
    • ホームケア施設
    • その他
  • 市場魅力分析：エンドユーザー別

第9章 世界市場分析・予測：地域別

  • 主な調査結果
  • 市場価値予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ地域
  • 市場魅力分析：地域別

第10章 北米市場の分析・予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：アプリケーション別、2017-2031年
    • リードベース
    • パッチベース
  • 市場価値予測：適応疾患別、2017-2031年
    • 狭心症
    • アテローム性動脈硬化症
    • 心不全
    • その他
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門クリニック
    • 診断センター
    • 在宅医療施設
    • その他
  • 市場価値予測：国別、2017-2031年
    • 米国
    • カナダ
  • 市場の魅力分析
    • アプリケーション別
    • 疾患別適応症別
    • エンドユーザー別
    • 国別

第11章 欧州市場の分析・予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：アプリケーション別、2017-2031年
    • リードベース
    • パッチベース
  • 市場価値予測：適応疾患別、2017-2031年
    • 狭心症
    • アテローム性動脈硬化症
    • 心不全
    • その他
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門クリニック
    • 診断センター
    • 在宅医療施設
    • その他
  • 市場価値予測：国別/小地域別、2017-2031年
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 市場の魅力分析
    • アプリケーション別
    • 疾患別適応症別
    • エンドユーザー別
    • 国別／サブリージョン別

第12章 アジア太平洋地域の市場分析・予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：アプリケーション別、2017-2031年
    • リードベース
    • パッチベース
  • 市場価値予測：適応疾患別、2017-2031年
    • 狭心症
    • アテローム性動脈硬化症
    • 心不全
    • その他
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門クリニック
    • 診断センター
    • 在宅医療施設
    • その他
  • 市場価値予測：国・地域別、2017-2031年
    • 中国
    • 日本
    • インド
    • オーストラリア・ニュージーランド
    • その他アジア太平洋地域
  • 市場の魅力分析
    • アプリケーション別
    • 疾患別適応症別
    • エンドユーザー別
    • 国別／サブリージョン別

第13章 ラテンアメリカの市場分析・予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：アプリケーション別、2017-2031年
    • リードベース
    • パッチベース
  • 市場価値予測：適応疾患別、2017-2031年
    • 狭心症
    • アテローム性動脈硬化症
    • 心不全
    • その他
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門クリニック
    • 診断センター
    • 在宅医療施設
    • その他
  • 市場価値予測：国別/小地域別、2017-2031年
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 市場の魅力分析
    • アプリケーション別
    • 疾患別適応症別
    • エンドユーザー別
    • 国別／サブリージョン別

第14章 中東・アフリカの市場分析・予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：アプリケーション別、2017-2031年
    • リードベース
    • パッチベース
  • 市場価値予測：適応疾患別、2017-2031年
    • 狭心症
    • アテローム性動脈硬化症
    • 心不全
    • その他
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門クリニック
    • 診断センター
    • 在宅医療施設
    • その他
  • 市場価値予測：国別/小地域別、2017-2031年
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 市場の魅力分析
    • アプリケーション別
    • 疾患別適応症別
    • エンドユーザー別
    • 国別／サブリージョン別

第15章 競合情勢

  • 市場競争者-競争マトリックス（企業階層別、企業規模別）
  • 市場シェア分析：企業別, 2022年
  • 企業プロファイル
    • BioTelemetry, Inc.
    • ScottCare
    • Biotricity Inc.
    • Welch Allyn
    • Applied Cardiac Systems, Inc.
    • Medicomp, Inc.
    • Preventice Solutions
    • Telerhythmics LLC
    • Zoll Medical Corporation
    • iRhythm Technologies, Inc.
図表

List of Tables

  • Table 1: Global overview of Surgical Mobile Cardiac Telemetry Device
  • Table 2: Regional overview of Surgical Mobile Cardiac Telemetry Device
  • Table 4: North America Overview of Surgical Mobile Cardiac Telemetry Device
  • Table 4: Asia Pacific overview of Surgical Mobile Cardiac Telemetry Device
  • Table 5: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 6: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 7: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 8: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 9: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 10: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 11: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 12: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 13: Europe Surgical Mobile Cardiac Telemetry Device Revenue (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 15: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 16: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 17: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 19: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 20: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 21: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 23: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 24: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 25: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 26: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 27: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 28: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031

List of Figures

  • Figure 01: Global Mobile Cardiac Telemetry Device Market
  • Figure 02: Global Mobile Cardiac Telemetry Device Market Size (US$ Mn) Forecast, 2017-2031
  • Figure 03: Global Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication (2022)
  • Figure 04: Global Mobile Cardiac Telemetry Device Market Value Share, by Application (2022)
  • Figure 05: Global Mobile Cardiac Telemetry Device Market Value Share, by End-user (2022)
  • Figure 06: Global Mobile Cardiac Telemetry Device Market Value Share, by Region (2022)
  • Figure 07: Global Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 08: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 09: Global Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 10: Global Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 11: Global Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 12: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 13: Global Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 14: Global Mobile Cardiac Telemetry Device Market Value Share, by Region, 2023-2031
  • Figure 15: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 16: North America Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 17: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 18: North America Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 19: North America Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 20: North America Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 21: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 22: North America Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 23: North America Mobile Cardiac Telemetry Device Market Value Share, by Country, 2023-2031
  • Figure 24: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 25: Europe Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 26: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 27: Europe Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 28: Europe Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 29: Europe Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 30: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 31: Europe Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 32: Europe Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022-2031
  • Figure 33: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 35: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 36: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 37: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 38: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 39: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 40: Asia Pacific Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 41: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022-2031
  • Figure 42: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 44: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 45: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 46: Latin America Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 47: Latin America Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 48: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Latin America Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 50: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022-2031
  • Figure 51: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 52: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 53: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 54: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 55: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 56: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 57: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Middle East & Africa Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 59: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022-2031
  • Figure 60: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Global Mobile Cardiac Telemetry Device Market Share Analysis, by Company, 2022 (Estimated)
  • Figure 62: Global Mobile Cardiac Telemetry Device Market Performance, by Company, 2022
  • Figure 63: Competition Matrix
目次
Product Code: TMRGL62667

Mobile Cardiac Telemetry Device Market - Scope of Report:

TMR's report on the global mobile cardiac telemetry device market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global mobile cardiac telemetry device market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mobile cardiac telemetry device market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the mobile cardiac telemetry device market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mobile cardiac telemetry device market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mobile cardiac telemetry device market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mobile cardiac telemetry device market.

The report delves into the competitive landscape of the global mobile cardiac telemetry device market. Key players operating in the global mobile cardiac telemetry device market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mobile cardiac telemetry device market profiled in this report.

Key Questions Answered in Global Mobile Cardiac Telemetry Device Market Report:

  • What is the sales/revenue generated by mobile cardiac telemetry device across all regions during the forecast period?
  • What are the opportunities in the global mobile cardiac telemetry device market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Mobile Cardiac Telemetry Device Market - Research Objectives and Research Approach:

The comprehensive report on the global mobile cardiac telemetry device market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global mobile cardiac telemetry device market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mobile cardiac telemetry device market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mobile Cardiac Telemetry Device Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Disease Indication Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Technological Advancement
  • 5.2. Regulatory Analysis
  • 5.3. Disease Incidence and Prevalence
  • 5.4. COVID-19 Impact Analysis

6. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Application, 2017 - 2031
    • 6.3.1. Lead-based
    • 6.3.2. Patch-based
  • 6.4. Market Attractiveness Analysis, by Application

7. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 7.3.1. Angina Pectoris
    • 7.3.2. Atherosclerosis
    • 7.3.3. Heart Failure
    • 7.3.4. Others
  • 7.4. Market Attractiveness, by Disease Indication

8. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Diagnostic Centers
    • 8.3.4. Home Care Settings
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Application, 2017-2031
    • 10.2.1. Lead-based
    • 10.2.2. Patch-based
  • 10.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 10.3.1. Angina Pectoris
    • 10.3.2. Atherosclerosis
    • 10.3.3. Heart Failure
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Specialty Clinics
    • 10.4.3. Diagnostic Centers
    • 10.4.4. Home Care Settings
    • 10.4.5. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Application
    • 10.6.2. By Disease Indication
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Application, 2017-2031
    • 11.2.1. Lead-based
    • 11.2.2. Patch-based
  • 11.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 11.3.1. Angina Pectoris
    • 11.3.2. Atherosclerosis
    • 11.3.3. Heart Failure
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Specialty Clinics
    • 11.4.3. Diagnostic Centers
    • 11.4.4. Home Care Settings
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Application
    • 11.6.2. By Disease Indication
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Application, 2017-2031
    • 12.2.1. Lead-based
    • 12.2.2. Patch-based
  • 12.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 12.3.1. Angina Pectoris
    • 12.3.2. Atherosclerosis
    • 12.3.3. Heart Failure
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Specialty Clinics
    • 12.4.3. Diagnostic Centers
    • 12.4.4. Home Care Settings
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Application
    • 12.6.2. By Disease Indication
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Application, 2017-2031
    • 13.2.1. Lead-based
    • 13.2.2. Patch-based
  • 13.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 13.3.1. Angina Pectoris
    • 13.3.2. Atherosclerosis
    • 13.3.3. Heart Failure
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Specialty Clinics
    • 13.4.3. Diagnostic Centers
    • 13.4.4. Home Care Settings
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Application
    • 13.6.2. By Disease Indication
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Application, 2017-2031
    • 14.2.1. Lead-based
    • 14.2.2. Patch-based
  • 14.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 14.3.1. Angina Pectoris
    • 14.3.2. Atherosclerosis
    • 14.3.3. Heart Failure
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Specialty Clinics
    • 14.4.3. Diagnostic Centers
    • 14.4.4. Home Care Settings
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. Brazil
    • 14.5.2. Mexico
    • 14.5.3. Rest of Latin America
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Application
    • 14.6.2. By Disease Indication
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. BioTelemetry, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Test Application Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. ScottCare
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Test Application Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Biotricity Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Test Application Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Welch Allyn
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Test Application Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Applied Cardiac Systems, Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Test Application Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Medicomp, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Test Application Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Preventice Solutions
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Test Application Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Telerhythmics LLC
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Test Application Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Zoll Medical Corporation
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Test Application Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. iRhythm Technologies, Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Test Application Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview